Abstract | PURPOSE: Eye involvement has long been appreciated in patients with chronic graft versus host disease (cGVHD). In particular, ocular complications are frequent and can be potentially severe in patients with steroid-refractory cGVHD, and therefore necessitate close monitoring. This prospective study was designed to describe eye manifestations of cGVHD in a large series of patients monitoring them before and after 1 year of extracorporeal photochemotherapy (ECP). ECP is a relatively new therapeutic approach based on the biological effects of psoralen 8-methoxypsoralen (8-MOP) and ultraviolet A light (UVA) on mononuclear cells collected by apheresis, and reinfused into the patient. METHODS: Only patients with steroid-refractory cGVHD under treatment with ECP, who developed cGVHD-related eye symptoms, were selected for the study. Ophthalmologic examination was repeated every 3 months. Only patients with complete recovery of the ocular manifestations and symptoms were considered responsive. RESULTS: In our study we observed eye alterations in 24 out of 140 patients (17%) with cGVHD. After 12 months of ECP, 10 out of 21 patients (48%) completely responded to the therapy. In all these cases the contribution of ECP was also essential in all the other organs subject to cGVHD. CONCLUSIONS: Further studies are necessary to clarify the role of ECP in patients with cGVHD, especially in associated eye manifestations. Although our experience is limited, it suggests that ECP could be a safe and effective therapy for steroid-refractory eye manifestations of cGVHD.
|
Authors | E Motolese, P Rubegni, S Poggiali, P A Motolese, G Marotta, L Russo, G D'Ascenzo, M R Carcagni, M Fruschelli, I Motolese, M Fimiani |
Journal | European journal of ophthalmology
(Eur J Ophthalmol)
2007 Nov-Dec
Vol. 17
Issue 6
Pg. 961-9
ISSN: 1120-6721 [Print] United States |
PMID | 18050124
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Chronic Disease
- Eye Diseases
(etiology, therapy)
- Female
- Graft vs Host Disease
(etiology, therapy)
- Hematologic Diseases
(therapy)
- Hematopoietic Stem Cell Transplantation
(adverse effects)
- Humans
- Male
- Methoxsalen
(therapeutic use)
- Middle Aged
- Photopheresis
(methods)
- Prospective Studies
- Transplantation, Homologous
- Ultraviolet Rays
|